Recurrence of infantile hemangioma after termination of propranolol treatment.
case_report · Level V
Where this comes from
- Record sourced from PubMed, PMID 24406852.
- Also identified by DOI 10.1097/SAP.0000000000000032.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Propranolol has been the first-line treatment for problematic infantile hemangioma (IH) since 2008. The recurrence of IHs after stopping treatment with propranolol was reported in several studies. Mechanisms underlying this phenomenon have not been elucidated so far. Our study is the first to show the general pathology of recurrence of IH after stopping treatment with propranolol. It can provide help for the clinical treatment of IHs.
Medical subject headings
- Adrenergic beta-Antagonists
- Hemangioma, Capillary
- Neoplasm Recurrence, Local
- Propranolol
- Skin Neoplasms